2026-01-02 - Analysis Report
Here's a comprehensive analysis of TransMedics Group Inc. (TMDX) based on the provided data.

**1. Return Rate Comparison:**

*   **Ticker:** TMDX (TransMedics Group Inc) - A medical technology company focused on organ preservation and transportation.
*   **TMDX Cumulative Return:** 199.35%
*   **S&P 500 (VOO) Cumulative Return:** 76.55%
*   **Divergence:** 122.8 (Relative Divergence: 61.3)
*   **Analysis:** TMDX has significantly outperformed the S&P 500. The divergence of 122.8 indicates a substantial performance gap. The relative divergence of 61.3 suggests that the current performance difference is in the middle range compared to its historical fluctuations versus the S&P 500.

**Alpha, Beta Analysis:**

|            Year |     CAGR |   MDD |   Alpha |   Beta |   Cap(B) |
|----------------:|---------:|------:|--------:|-------:|---------:|
|        2020-2022 |   252% |  83.5% |   234% |    1.3 |      2.1 |
|        2021-2023 |   246% |  80.5% |   218% |    1.7 |      2.7 |
|        2022-2024 |   293% |  85.5% |   263% |    1.8 |      2.1 |
|        2023-2025 |    93% |  85.5% |    25% |    1.4 |      4.2 |

*   **CAGR (Compound Annual Growth Rate):** TMDX has experienced very high CAGR over the analyzed periods, although the most recent period (2023-2025) shows a significant decrease in growth rate.
*   **MDD (Maximum Drawdown):** The MDD is consistently high (around 80-85%), indicating significant price volatility and potential risk of loss.
*   **Alpha:** The high alpha values suggest that TMDX has consistently outperformed its expected return based on its beta.
*   **Beta:** The beta values are above 1, indicating that TMDX is more volatile than the overall market. The Beta has generally increased over the periods, suggesting an increasing sensitivity to market movements, although the most recent period shows a decrease.
*   **Cap(B):** The market cap in billions is a factor in the stock's volatility.

**2. Recent Stock Price Fluctuations:**

*   **Current Close:** 121.65
*   **Previous Close:** 121.92
*   **Change:** -0.22
*   **5-day SMA:** 123.564
*   **20-day SMA:** 128.3245
*   **60-day SMA:** 126.1772
*   **Analysis:** The stock price is currently slightly down compared to the previous close. The 5-day SMA is below the 20-day and 60-day SMAs, indicating a potential short-term downward trend.

**3. Index Indicators and Expected Return:**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended) - *Note: An MRI of 0.9, according to the provided scale, suggests high investment recommendation, which seems counterintuitive given the description. This might be a misinterpretation or error in the MRI calculation.*
*   **RSI:** 34.01 - The RSI is below 30, suggesting the stock may be oversold.
*   **PPO:** -0.7479 - The PPO (Percentage Price Oscillator) being negative indicates that the short-term moving average is below the long-term moving average, suggesting a potential downtrend.
*   **Hybrid Signal:** "cash_0%_Buy 100% of cash (7 shares - Very Safe - MRI:0.90) Monthly invest 1.2% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)" - The hybrid signal recommends a full investment with no cash allocation and suggests a monthly investment strategy.
*   **Recent (20 days) relative divergence change:** -4.5 (단기하락 - Short-term decline) - This confirms the recent underperformance relative to its historical trend versus the S&P 500.
*   **Expected Return (%):** 208.76 - This is a very high expected return, indicating significant potential upside if held long-term (over 2 years).

**4. Recent News & Significant Events:**

*   **Positive Sentiment:** The majority of recent news articles express positive sentiment towards TransMedics. Several articles highlight TMDX as a strong growth stock and a good investment opportunity.
*   **Analyst Upgrades:** Wall Street Zen upgraded its stock rating for TransMedics.
*   **Insider Sales:** One article mentions opinions on recent insider sales, which could be a point of concern and requires further investigation.
*   **New Hires:** News about new hires receiving stock options and units with long vesting periods suggests confidence in the company's long-term prospects.

**4-2. Analyst Opinions:**

*   **Consensus:** Buy (~1.67)
*   **Opinions:** 11
*   **Target Price (avg/high/low):** 144.73 / 170.00 / 114.00
*   **Recent Rating Changes:** No changes are provided.
*   **Analysis:** The analyst consensus is generally positive, with a "Buy" rating and a target price significantly higher than the current price, suggesting potential upside.

**5. Comprehensive Analysis:**

TMDX has demonstrated strong historical outperformance compared to the S&P 500, driven by high CAGR and alpha. However, this outperformance comes with high volatility, as evidenced by its high MDD and beta. Recent data suggests a potential short-term downward trend, with the stock price below its recent moving averages and a negative change in relative divergence.

Despite the short-term concerns, the overall outlook for TMDX appears positive. Analyst consensus is favorable, with a "Buy" rating and a target price significantly higher than the current price. Recent news articles also express positive sentiment, highlighting the company's growth potential. The high expected return of 208.76% further reinforces this positive outlook.

**Recommendations & Considerations:**

*   **Investment Recommendation:** Given the MRI of 0.9, high expected return and analyst consensus, the information suggests a buy.
*   **Risk Management:** Given the high volatility (high Beta and MDD), investors should be aware of the potential for significant price fluctuations and carefully manage their risk exposure. The insider sales need closer scrutiny.
*   **Long-Term Focus:** The high expected return is contingent on a long-term investment horizon (more than 2 years).
*   **Monitor News and Financials:** Investors should continue to monitor news and financial reports to stay informed about the company's performance and any potential risks. The recent decline should be watched, to see if there are underlying reasons for the movement.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.